ROLE OF THE QUANTITATIVE BCL2/IGH@ REARRANGEMENT EVALUATION IN PATIENTS AFFECTED BY FOLLICULAR LYMPHOMA: THE ANCILLARY STUDY OF THE FIL-FOLL05 TRIAL

被引：0
|
作者：
Galimberti, S. [1 ]
Luminari, S. [2 ]
Ciabatti, E. [3 ]
Dondi, A. [2 ]
Ladetto, M. [4 ]
Piccaluga, P. [5 ]
Del Giudice, I. [6 ]
Palumbo, G. [7 ]
Vitolo, U. [8 ]
Gaidano, G. [9 ]
Carella, A. [10 ]
Petrini, M. [11 ]
Federico, M. [2 ]
机构：
[1] Univ Pisa, Hematol Clin & Expt Med, Pisa, Italy
[2] Univ Modena & Reggio Emilia, Oncol, Modena, Italy
[3] Hematol Clin & Expt Med, Pisa, Italy
[4] Azienda Osped Univ Le Molinette, Hematol 2, Oncol, Turin, Italy
[5] Univ Bologna, Expt Diagnost & Special Med, Bologna, Italy
[6] Univ Roma La Sapienza, Cellular Biotechnol & Hematol, Rome, Italy
[7] Azienda Osped Ferrarotto, Hematol, Catania, Italy
[8] Citta Sci & Salute, Hematol, Turin, Italy
[9] Univ Piemonte Nord Orientale, Azienda Osped Univ Carita, Novara, Italy
[10] Azienda Osped San Martino, Hematol, Genoa, Italy
[11] Univ Pisa, Hematol Clin & Expt Med, Cellular Biotechnol & Hematol, Pisa, Italy
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S582
引用
收藏
页码：244 / 244
页数：1
相关论文
共 11 条
  • [1] Minimal Residual Disease Evaluated As Bcl2/Igh Rearrangement After Conventional Treatment Does Significantly Impact On Progression-Free Survival of Patients Affected by Follicular Lymphoma: The Experience of the Ancillary Trial Conducted by the Fondazione Italiana Linfomi (FIL)
    Galimberti, Sara
    Luminari, Stefano
    Ciabatti, Elena
    Testi, Rossana
    Dondi, Alessandra
    Ladetto, Marco
    Piccaluga, Pier Paolo, Sr.
    Del Giudice, Ilaria
    Gazzola, Anna
    Monitillo, Luigia
    Mantoan, Barbara
    della Starza, Irene
    Cavalli, Marzia
    Arcaini, Luca
    Tucci, Alessandra
    Di Raimondo, Francesco
    Rigacci, Luigi
    Pulsoni, Alessandro
    Vitolo, Umberto
    Vallisa, Daniele
    Bertoldero, Giovanni
    Gaidano, Gianluca
    Petrini, Mario
    Federico, Massimo
    BLOOD, 2012, 120 (21)
  • [2] MRD Monitoring By Euroclonality IGH Based NGS Approach Predicts Outcome in Follicular Lymphoma Patients Lacking a Conventional BCL2::IGH Marker: A Substudy from the Fondazione Italiana Linfomi (FIL) FOLL12 Trial
    Genuardi, Elisa
    Alessandria, Beatrice
    Della Starza, Irene
    Guerrini, Francesca
    Bomben, Riccardo
    Drandi, Daniela
    Ferrante, Martina
    Bono, Clara
    Soscia, Roberta
    Bittolo, Tamara
    Ragaini, Simone
    Mancuso, Salvatrice
    Cencini, Emanuele
    Di Renzo, Nicola
    Mannarella, Clara
    Murineddu, Marco
    Stefoni, Vittorio
    Centurioni, Riccardo
    Baldini, Luca
    Civita, Aurora Maria
    BLOOD, 2023, 142
  • [3] MRD MONITORING BY EUROCLONALITY IGH BASED NGS APPROACH PROVIDES OUTCOME PREDICTION IN FOLLICULAR LYMPHOMA PATIENTS LACKING A CONVENTIONAL BCL2∥IGH MARKER| BIOLOGICAL RESULTS FROM THE FONDAZIONE ITALIANA LINFOMI (FIL) FOLL12 TRIAL
    Genuardi, E.
    Alessandria, B.
    Della Starza, I.
    Guerrini, F.
    Bomben, R.
    Drandi, D.
    Ferrante, M.
    Bono, C.
    Soscia, R.
    Bittolo, T.
    Ragaini, S.
    Mancuso, S.
    Cencini, E.
    Di Renzo, N.
    Mannarella, C.
    Murineddu, M.
    Stefoni, V.
    Centurioni, R.
    Baldini, L.
    Civita, A. M.
    Gattei, V.
    Galimberti, S.
    Del Giudice, I.
    Bruno, B.
    Federico, M.
    Ladetto, M.
    Pott, C.
    Luminari, S.
    Ferrero, S.
    HAEMATOLOGICA, 2024, 109 : 36 - 37
  • [4] The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL)
    Luminari, S.
    Biasoli, I.
    Versari, A.
    Rattotti, S.
    Bottelli, C.
    Rusconi, C.
    Merli, F.
    Spina, M.
    Ferreri, A. J. M.
    Zinzani, P. L.
    Gallamini, A.
    Franceschetto, A.
    Boccomini, C.
    Franceschetti, S.
    Salvi, F.
    Raimondo, F. D.
    Carella, A. M.
    Micol, Q.
    Balzarotti, M.
    Musto, P.
    Federico, M.
    ANNALS OF ONCOLOGY, 2014, 25 (02) : 442 - 447
  • [5] A real-time (PCR) for a real life ...? Quantitative evaluation of BCL2/IGH in follicular lymphoma and its implications for clinical practice
    Janikova, Andrea
    Mareckova, Andrea
    Dvorakova, Dana
    Bortlicek, Zbynek
    Tichy, Boris
    Navratil, Milan
    Kral, Zdenek
    Pospisilova, Sarka
    Mayer, Jiri
    EXPERIMENTAL HEMATOLOGY, 2012, 40 (07) : 528 - 539
  • [6] Commercial LightCycler®-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma
    M. Kornacker
    B. Kornacker
    C. Schmitt
    E. Leo
    A. D. Ho
    M. Hensel
    Annals of Hematology, 2009, 88 : 43 - 50
  • [7] Commercial LightCycler®-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma
    Kornacker, M.
    Kornacker, B.
    Schmitt, C.
    Leo, E.
    Ho, A. D.
    Hensel, M.
    ANNALS OF HEMATOLOGY, 2009, 88 (01) : 43 - 50
  • [8] Quantitative PCR Analysis for Bcl-2/IgH in a Phase III Study of Yttrium-90 Ibritumomab Tiuxetan As Consolidation of First Remission in Patients With Follicular Lymphoma
    Goff, Lindsey
    Summers, Karin
    Iqbal, Sameena
    Kuhlmann, Jens
    Kunz, Michael
    Louton, Tom
    Hagenbeek, Anton
    Morschhauser, Franck
    Putz, Barbara
    Lister, Andrew
    Rohatiner, Ama
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) : 6094 - 6100
  • [9] REAL-TIME QUANTITATIVE PCR ANALYSIS FOR BCL2/IGH IN THE PHASE III FIRST-LINE INDOLENT TRIAL OF (90Y)-IBRITUMOMAB TIUXETAN AS CONSOLIDATION OF FIRST REMISSION IN ADVANCED-STAGE FOLLICULAR LYMPHOMA
    Goff, L.
    Summers, K.
    Iqbal, S.
    Kuhlman, J.
    Kunz, M.
    Louton, T.
    Hagenbeek, A.
    Lister, T.
    Rohatiner, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 357 - 357
  • [10] Quantitative real-time PCR of circulating bcl2/IgH+ cells at diagnosis, after therapy and during follow-up predicts long-term outcome and imminent relapse in Patients with follicular Lymphoma
    Zohren, F.
    Bruns, I
    Barth, J.
    Pechtel, S.
    Fenk, R.
    Schroeder, T.
    Maschmeyer, G.
    Kofahl-Krause, D.
    Niederle, N.
    Heil, G.
    Losem, C.
    Welslau, M.
    Germing, U.
    Kronenwett, R.
    Rummel, M. J.
    Haas, R.
    Kobbe, G.
    ONKOLOGIE, 2010, 33 : 158 - 158
12